Penicillin V Potassium Oral Solution recalled for subpotency
Teva Pharmaceuticals USA is recalling certain lots of Penicillin V Potassium for Oral Solution nationwide because the medication is subpotent—containing less active ingredient than labeled. The recall affects 100 mL and 200 mL bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily by the manufacturer. The source text states the reason for recall is subpotency, and no illnesses or injuries are reported. Under the severity rubric, Class II recalls without reported hospitalization or injury are classified as Moderate (score 2).
Plain-English summary
Teva Pharmaceuticals USA is recalling specific lots of Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL due to subpotency. The affected products are 100 mL bottles (NDC 00093-4125-73, approximately 86,790 units) and 200 mL bottles (NDC 00093-4125-74, approximately 25,416 units) when mixed.
The specific lots under recall are: for 100 mL bottles—Lot 35446365A (Exp 03/2022), Lot 35447040A (Exp 08/2022), and Lot 35447948B (Exp 03/2023); for 200 mL bottles—Lot 35446318B (Exp 05/2022) and Lot 35447947A (Exp 03/2023). The product was distributed nationwide.
This is a voluntary recall initiated by Teva Pharmaceuticals USA and classified as Class II by the FDA. Patients taking the affected product may not be receiving the full therapeutic dose of penicillin. Consumers should contact their healthcare provider or pharmacist if they have received one of the recalled lots. Do not stop taking penicillin without consulting your doctor, as stopping antibiotic treatment prematurely can be harmful.
The recalled product
- Product
- Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454
- Manufacturer
- Teva Pharmaceuticals USA
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- a) Lots
- 35446365A
- Exp 03/2022
- 35447040A
- Exp 08/2022 & 35447948B
- Exp 03/2023. b) Lots 35446318B
- Exp 05/2022 & 35447947A
- Exp 03/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22